Arqule


3 Biotechs with Upcoming Data to Watch

Written by Dan Cohen and Scott Matusow Cytokinetics (NASDASQ:CYTK) looks to turn around their fortunes following last year’s unsuccessful readout of Tirasemtiv in …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts